Condition: Invasive Fungal Infections · Sponsor: Peter MacCallum Cancer Centre, Australia
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
This description comes directly from the study's public registry record.
Abby Douglas · 03 855 96136 · Abby.Douglas@petermac.org
Beatrice Sim · Beatrice.Sim@petermac.org
Always discuss trial participation with your own doctor first.
| Peter MacCallum Cancer Centre | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06105411